ENTOD Pharmaceuticals secures patent for its insulin eye drop

Currently at the pre-clinical stage of development, the patented insulin eye drops are being investigated as a potential novel therapeutic approach to address unmet needs in ophthalmic care, the Mumbai-based company said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/IVdDPMv
via IFTTT